Science & Enterprise subscription

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn

Affiliations

Science Blogs
ACI Profile for Alan Kotok
Featured in Alltop

Trial to Examine Immune System Workings

Unlike conventional clinical studies testing a particular treatment, this trial aims to explore in more detail the body’s interactions with a class of drugs, in this case vaccines. . . . → Read More: Trial to Examine Immune System Workings

Growing Engineered Algae Outdoors Shown Feasible, Safe

A test of cultivating genetically engineered algae in outdoor tanks shows the production technique is feasible and does not pose risks to native algae populations. . . . → Read More: Growing Engineered Algae Outdoors Shown Feasible, Safe

23andMe, Grünenthal Partner on Pain Genetics

A personal genetics company in Silicon Valley is collaborating with a German pharmaceutical company to better understand the relationship between genetics and pain. . . . → Read More: 23andMe, Grünenthal Partner on Pain Genetics

Neural Technology Research Centers Launched

Research centers for accelerating new technologies that tackle nervous system disorders are opening at two universities in the U.S., with industry partners. . . . → Read More: Neural Technology Research Centers Launched

FDA, Emulate to Test Organs-on-Chips for Drug Toxins

A joint venture between Food and Drug Administration and a developer of chip devices simulating human organs, is evaluating the chips as a way to test new drugs for toxic effects. . . . → Read More: FDA, Emulate to Test Organs-on-Chips for Drug Toxins

Antibody Shows Promise Against Marburg Virus Infections

Tests with lab animals show an experimental synthetic antibody protects against deadly Marburg and Ravn viruses as long as 5 days following infections. . . . → Read More: Antibody Shows Promise Against Marburg Virus Infections

Prodrugs Designed to Better Target Cancer Therapies

A delivery mechanism is being developed to package cancer drugs in a nanoscale precursor state that reacts only in tumor regions, to protect against adverse effects. . . . → Read More: Prodrugs Designed to Better Target Cancer Therapies

CARB-X Commits $48M for Antibiotic Resistance R&D

A public-private partnership is spending $48 million in grants to biotechnology companies for research on treatments and diagnostics to counter antibiotic resistance, with half of that amount distributed immediately. . . . → Read More: CARB-X Commits $48M for Antibiotic Resistance R&D

Climate-Resistant Oilseed Crop Plant Developed

An academic-industry team developed a new crop plant variety that produces cooking oil like rapeseed or canola, but in a warmer and dryer climate. . . . → Read More: Climate-Resistant Oilseed Crop Plant Developed

Regeneron to Sequence 500K UK Biobank Genomes

A biotech company and health database center are partnering with drug maker GlaxoSmithKline to produce genomic data on 500,000 individuals for drug discovery. . . . → Read More: Regeneron to Sequence 500K UK Biobank Genomes